# Chemomab Therapeutics Ltd. (CMMB)

> Source: Nexqual · https://nexqual.com/CMMB · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Chemomab Therapeutics Ltd. (CMMB), nexqual.com/CMMB" · informational, not investment advice.

**Price:** USD 1.29 (+0.00% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 1.29 · day 1.26–1.36 · 52w 1.05–3.45 · market cap $9.5M · NCM

## Key facts
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $7K; 1 not under a Rule 10b5-1 plan ($7K).
- Total return with dividends: 1Y -60.7% vs S&P 500 +18.1%; 5Y -96.5% vs S&P 500 +85.1%.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2019 | FY2019 | FY2020 | FY2021 | FY2022 | TTM |
|---|---|---|---|---|---|---|
| Net income | -$13.8M | -$27.1M | -$6.0M | -$12.5M | -$27.6M | -$31.3M |
| EPS (diluted) | $69.76 | $50.56 | $0.18 | $0.24 | $0.48 | — |
| Free cash flow | -$14.4M | -$16.6M | -$5.3M | -$12.6M | -$20.4M | -$23.9M |
| Cash + short-term investments | $7.5M | $17.6M | $11.7M | $15.2M | $13.5M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Mar 31, 2023)
P/B 0.3x · FCF yield -252.84% · Earnings yield -331.07%

## Insider sales (SEC Form 4, open-market, last ~7 months)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan |
|---|---|---|---|---|---|---|
| 2026-08-27…2026-08-28 | Cohen Neil Harris | Director | 2,304 | $7K | 6.5% | No |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -60.7% | -96.5% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -60.8% | -48.6% |
| Volatility (annualized) | 97.5% | 82.7% |
| Max drawdown | -65.0% (Oct 2025→Sep 2026) | -96.8% (Oct 2021→Oct 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/CMMB · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt